Feng-ming Tien
TPQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications
Real-world experience with gilteritinib maintenance following allogeneic transplantation in relapsed/refractory AML patients harboring FLT3 mutations.
Journal: Blood research
Published: January 01, 2026
Prognostic implications of genetic and transcriptomic abnormalities in MDS according to IPSS-R, IPSS-M, and the International Consensus Classification.
Journal: Blood cancer journal
Published: September 09, 2025
Prognostic impact of lymphocyte to monocyte ratio in patients with myelodysplastic neoplasms/syndromes.
Journal: Blood research
Published: September 03, 2025
Clinical Manifestations and Ophthalmic Outcomes of Leukemic Retinopathy and Optic Neuropathy in Patients With Acute Leukemia.
Journal: Investigative ophthalmology & visual science
Published: August 01, 2025
Prognostic impact of co-occurring FLT3 mutations across molecular subgroups in intensively treated acute myeloid leukemia: insights from real-world genomic data.
Journal: Blood cancer journal
Published: July 19, 2025
Molecular Milestones and Survival Outcomes of Ponatinib Treatment in Patients With Chronic Myeloid Leukemia and Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia: A Real-World Analysis.
Journal: Clinical lymphoma, myeloma & leukemia
Published: July 06, 2025
Genomic and transcriptomic characterization of acute myeloid leukaemia with IL3RA overexpression: Prognostic and therapeutic implications revisited.
Journal: British journal of haematology
Published: July 01, 2025
Real-World Evidence on Outcomes and Safety of Ropeginterferon Alfa-2b in Patients With Myeloproliferative Neoplasms: A Retrospective Cohort Study.
Journal: Clinical lymphoma, myeloma & leukemia
Published: May 03, 2025
Prognostic implications of myelodysplasia-related gene mutations in NPM1-mutated acute myeloid leukemia: a systematic review and meta-analysis.
Journal: Haematologica
Published: April 22, 2025
Genomic and transcriptomic determinants of clinical outcomes in patients with AML and DNMT3A mutations.
Journal: Blood cancer journal
Published: February 13, 2025
Epidemiology, Treatment Outcomes, and Prognosis of Myelodysplastic Syndromes/Neoplasms in Taiwan: Real-World Insights and Trends.
Journal: Clinical lymphoma, myeloma & leukemia
Published: November 25, 2024
Comprehensive Characterization of Overt Myelofibrosis in an Asian Cohort: Phenotype, Mutation Landscape and Discordance Among Scoring Systems.
Journal: Hematological oncology
Published: November 18, 2024
Last Updated: 09/26/2026